Clinical Trials Logo

Clinical Trial Summary

Decompressive craniectomy has been reported for the treatment of patients with aneurysmal subarachnoid hemorrhage (aSAH). But no prospective randomised controlled trials have yet been undertaken to confirm its effect.The purpose of the study is to determine whether decompressive craniectomy combine aneurysm clipping surgery or endovascular coiling will improve clinical outcomes of poor-grade aSAH patients.


Clinical Trial Description

Aneurysmal subarachnoid hemorrhage (aSAH) is a worldwide health burden with high fatality and permanent disability rates. Decompressive craniectomy, which is beneficial in patients with malignant middle cerebral artery infarction, may indirectly relieve the mass effect, decrease perihematomal tissue pressure, improve blood flow, reduce secondary brain damage and improve outcome without further damage to the brain due to surgery. Early therapy with either surgical clipping or neuroradiologic intervention with endovascular coiling is the primary treatment for aSAH. But whether decompressive craniectomy should be employed during the clipping surgery or immediately after coil embolization still have considerable controversy. 80 patients will be recruited to the trial over 12 months. Follow-up will take 6 months with analysis and reporting taking 6 months. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02995928
Study type Interventional
Source Tang-Du Hospital
Contact Yan Qu, M.D Ph.D
Phone 86-18629074363
Email [email protected]
Status Recruiting
Phase N/A
Start date May 4, 2017
Completion date July 2018

See also
  Status Clinical Trial Phase
Recruiting NCT04583163 - Variability in Transcranial Doppler Technique in Neuro-Critical Care Patients
Terminated NCT02893826 - Safety/Pharmacokinetic Study Comparing Intracisternal EG-1962 to Standard of Care Enteral Nimodipine in Adults With aSAH Phase 1
Unknown status NCT01567449 - Risk Factors for Aneurysm Rebleeding N/A
Not yet recruiting NCT04512859 - Stellate Ganglion Block in Preventing Cerebral Vasospasm Secondary to Subarachnoid Hemorrhage N/A
Completed NCT04415736 - Artificial Intelligence in Subarachnoid Hemorrhage
Recruiting NCT04649398 - Cerebral Nimodipine Concentrations Following Oral, Intra-venous and Intra-arterial Administration
Recruiting NCT04945603 - Poor Grade Aneurysmal Subarachnoid Hemorrhage Study Group
Completed NCT03318783 - Subarachnoid Hemorrhage and Soluble Epoxide Hydrolase Inhibition Trial Phase 1/Phase 2
Not yet recruiting NCT04696523 - Effect of Xenon on Brain Injury After Aneurysmal Subarachnoid Hemorrhage Phase 2
Recruiting NCT03115905 - A Registry Study for Emergency Medical Service of Aneurysmal Subarachnoid Hemorrhage in China
Not yet recruiting NCT01836848 - Non-invasive Measuring of Cerebral Perfusion After Severe Brain Injury With Near-infrared-spectroscopy and ICG N/A
Recruiting NCT04449666 - Hippocampal Volume and Memory Functions in Aneurysmal Subarachnoid Hemorrhage
Recruiting NCT03987139 - Cerebral Autoregulation in Patients With Aneurysmal SubArachnoid Haemorrhage N/A
Recruiting NCT03569540 - Glibenclamide in Aneurysmatic Subarachnoid Hemorrhage Phase 4
Recruiting NCT03377049 - Acetazolamide Challenge With Perfusion in the Prediction of Cerebral Vasospasm Phase 4
Terminated NCT02790632 - Study of EG-1962 Compared to Standard of Care Oral Nimodipine in Adults With Aneurysmal Subarachnoid Hemorrhage Phase 3
Not yet recruiting NCT03094975 - A Multicenter Registry Study of Aneurysmal SAH N/A
Recruiting NCT03153748 - New Therapeutic System of Ruptured Intracranial Aneurysms Based on Big Data From Chinese Population N/A
Active, not recruiting NCT03691727 - Induced Suppression of Platelets Activity in Aneurysmal SAH Management (iSPASM) Phase 1/Phase 2
Not yet recruiting NCT04728438 - Effect of Targeted Temperature Management on Cerebral Autoregulation in Patients With Neurocritical Diseases